BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8048895)

  • 1. A comparison of Southern blot and polymerase chain reaction as techniques to identify loss of DNA heterozygosity in colorectal cancer.
    Hewett PJ; Firgaira F; Morley A
    Aust N Z J Surg; 1994 Aug; 64(8):556-7. PubMed ID: 8048895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable number of tandem repeat (VNTR) polymorphism at locus D17S5 (YNZ22) in four ethnically defined human populations.
    Deka R; De Croo S; Yu LM; Ferrell RE
    Hum Genet; 1992; 90(1-2):86-90. PubMed ID: 1427793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction.
    Peinado MA; Malkhosyan S; Velazquez A; Perucho M
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10065-9. PubMed ID: 1359533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction-based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms.
    Dockhorn-Dworniczak B; Poremba C; Dantcheva R; Stücker A; Brömmelkamp E; Blasius S; Mellin W; Roessner A; Yandell DW; Böcker W
    Virchows Arch; 1994; 424(4):337-42. PubMed ID: 7911380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of the pentanucleotide repeat d(AAAAT) within intron 1 of the human tumor suppressor gene p53 (17p13.1).
    Hahn M; Fislage R; Pingoud A
    Hum Genet; 1995 Apr; 95(4):471-2. PubMed ID: 7705850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
    Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG
    Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid diagnosis of Miller-Dieker syndrome and isolated lissencephaly sequence by the polymerase chain reaction.
    Batanian JR; Ledbetter SA; Wolff RK; Nakamura Y; White R; Dobyns WB; Ledbetter DH
    Hum Genet; 1990 Oct; 85(5):555-9. PubMed ID: 2227942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic heterogeneity of certain sporadic colorectal cancers].
    Vincent-Salomon A; Olschwang S; Hamelin R; Remvikos Y; Laurent-Puig P; Thomas G
    Gastroenterol Clin Biol; 1993; 17(10):733-9. PubMed ID: 8288082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A variable tandem repeat locus mapped to chromosome band 10q26 is amplified and rearranged in leukocyte DNAs of two cancer patients.
    Colb M; Yang-Feng T; Francke U; Mermer B; Parkinson DR; Krontiris TG
    Nucleic Acids Res; 1986 Oct; 14(20):7929-37. PubMed ID: 3022240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism.
    Jones MH; Nakamura Y
    Genes Chromosomes Cancer; 1992 Jul; 5(1):89-90. PubMed ID: 1384667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer.
    Khine K; Smith DR; Goh HS
    Cancer; 1994 Jan; 73(1):28-35. PubMed ID: 8275434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras mutation and loss of heterozygosity of chromosome 17p and survival in colorectal cancer.
    Fung C; Bragg T; Newland R; Dent O; Nicholson G; Bokey L; Chapuis P
    Aust N Z J Surg; 1997 May; 67(5):239-44. PubMed ID: 9152151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of frequent involvement of modifier of Min(APC) in sporadic colorectal cancer.
    Kahlenberg MS; Stoler DL; Petrelli NJ; Rodriguez-Bigas M; Weber TK; Anderson GR
    Ann Surg Oncol; 1998 Mar; 5(2):181-5. PubMed ID: 9527272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma.
    Iacopetta B; DiGrandi S; Dix B; Haig C; Soong R; House A
    Eur J Cancer; 1994; 30A(5):664-70. PubMed ID: 8080684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
    Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
    Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
    Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
    Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human breast cancer: frequent p53 allele loss and protein overexpression.
    Singh S; Simon M; Meybohm I; Jantke I; Jonat W; Maass H; Goedde HW
    Hum Genet; 1993 Feb; 90(6):635-40. PubMed ID: 8444469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.
    Campo E; Miquel R; Jares P; Bosch F; Juan M; Leone A; Vives J; Cardesa A; Yague J
    Cancer; 1994 Jun; 73(12):2913-21. PubMed ID: 8199988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.